Quick Answer
Zivo Bioscience, Inc. reported Stockholders Equity of -$514.9 thousand for fiscal year 2024.
Zivo Bioscience, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$514.9K | +76.7% |
| 2023 | -$2.21M | -20666.7% |
| 2022 | -$10.6K | -100.2% |
| 2021 | $6.04M | +153.4% |
| 2020 | -$11.31M | -35.6% |
| 2019 | -$8.34M | +62.6% |
| 2018 | -$22.28M | -36.7% |
| 2017 | -$16.30M | -19.7% |
| 2016 | -$13.62M | -43.4% |
| 2015 | -$9.50M | -49.1% |
| 2014 | -$6.37M | +33.6% |
| 2013 | -$9.59M | -142.5% |
| 2012 | -$3.96M | -94.7% |
| 2011 | -$2.03M | -113.5% |
| 2010 | -$951.7K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.29M | -57.8% | -29.4% |
| June 30, 2025 | -$2.54M | -10.7% | -57.1% |
| March 31, 2025 | -$1.62M | +28.7% | -214.1% |
| December 31, 2024 | -$514.9K | +76.7% | +75.3% |
| September 30, 2024 | -$2.08M | -90.4% | +9.3% |
| June 30, 2024 | -$2.30M | +27.0% | -1.2% |
| March 31, 2024 | -$2.27M | -30.3% | -2.9% |
| December 31, 2023 | -$2.21M | -20666.7% | -101.6% |
- Zivo Bioscience, Inc. showed an increase of +76.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2024 period, Zivo Bioscience, Inc.’s stockholders equity has grown by 45.9% (from -$951.7 thousand to -$514.9 thousand).
- The most recent figure is from Zivo Bioscience, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 18, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: